Antibe Therapeutics To Pay Nuance $24M In Licensing Fight
Canadian company Antibe Therapeutics Inc. said Monday it has lost its dispute in arbitration with Chinese firm Nuance Pharma Ltd. over a licensing deal for an anti-inflammatory drug, saying it has...To view the full article, register now.
Already a subscriber? Click here to view full article